Technology · India Bureau
Zomato Chief Defends Healthcare Ambitions Amid Medical Skepticism
Deepinder Goyal has pushed back against criticism of building a healthcare venture in India, as his company's Temple device faces scrutiny from medical professionals over its scientific validity.
LSN India ·
Zomato founder and CEO Deepinder Goyal has responded to skepticism about launching a healthcare startup in India, offering a brief but pointed riposte to critics who question the viability of such ventures in the domestic market.
The response comes as Temple, a health-focused device from Zomato's portfolio, opened for pre-orders on November 1 at Rs 85,000. The product announcement has drawn critical attention from medical professionals who have questioned the scientific basis of the device's claimed benefits and functionality.
The exchange reflects broader tensions in India's emerging health-tech space, where entrepreneurs from non-medical backgrounds are increasingly venturing into healthcare solutions. While some argue that technological innovation and business acumen can disrupt traditional healthcare delivery, medical practitioners often express concerns about unvalidated claims and the potential risks to consumers.
Zomato's foray into healthcare follows the company's diversification strategy beyond food delivery. The company has previously ventured into quick commerce and other sectors, seeking to build a broader ecosystem of services for Indian consumers.
The controversy surrounding Temple underscores the regulatory and credibility challenges facing health-tech startups in India, where consumer trust and medical validation remain critical factors for success and market adoption.